↓ Skip to main content

Dove Medical Press

A rehabilitation program for lung cancer patients during postthoracotomy chemotherapy

Overview of attention for article published in OncoTargets and therapy, March 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
87 Mendeley
Title
A rehabilitation program for lung cancer patients during postthoracotomy chemotherapy
Published in
OncoTargets and therapy, March 2014
DOI 10.2147/ott.s57262
Pubmed ID
Authors

Amy J Hoffman, Ruth Ann Brintnall, Alexander von Eye, Lee W Jones, Gordon Alderink, Lawrence H Patzelt, Jean K Brown

Abstract

The objective of this pilot study was to describe the effects of a 16-week home-based rehabilitative exercise program on cancer-related fatigue (CRF), other symptoms, functional status, and quality of life (QOL) for patients with non-small cell lung cancer (NSCLC) after thoracotomy starting within days after hospital discharge and continuing through the initiation and completion of chemotherapy.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 2%
Denmark 1 1%
United States 1 1%
Unknown 83 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 21%
Researcher 9 10%
Student > Ph. D. Student 8 9%
Student > Bachelor 8 9%
Student > Doctoral Student 6 7%
Other 14 16%
Unknown 24 28%
Readers by discipline Count As %
Medicine and Dentistry 28 32%
Nursing and Health Professions 14 16%
Sports and Recreations 5 6%
Psychology 2 2%
Materials Science 2 2%
Other 7 8%
Unknown 29 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2014.
All research outputs
#20,823,121
of 25,584,565 outputs
Outputs from OncoTargets and therapy
#1,573
of 2,967 outputs
Outputs of similar age
#174,984
of 236,752 outputs
Outputs of similar age from OncoTargets and therapy
#13
of 17 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,967 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,752 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.